Resources from the same session
Taking aim at the undruggable: Mutant-specific KRAS inhibitors, insights and perspectives
Presenter: Melissa Johnson
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
Novel mutant-selective EGFR/HER2 kinase inhibitors: Insights and perspectives
Presenter: Capucine Baldini
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
Mutant-selective degradation by kinase-targeting PROTACs: current developments
Presenter: Tanya Dorff
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mutant specific inhibitors
Resources:
Webcast